Families and four-legged friends walked among the bluebells to make a difference for Heart of Kent Hospice. On Sunday, May 4th, Bedfont® teamed up with joint headline sponsors NewMed Limited and participated in this year's Bluebell Walk, hosted by Heart...
Read More
How FeNO can Influence the Patient Pathway – By Carol Stonham
The latest UK asthma guidelines1 have identified how Fractional exhaled Nitric Oxide (FeNO) testing fits into the diagnosis and ongoing management of asthma. The guidelines are based on the latest clinical evidence, cost-effectiveness, and cost-effective modelling, so they are strongly...
Read More
Breaking Down Barriers: Why Access to Asthma Care Is Still Not Equal
Asthma is one of the most common long-term health conditions, so why does access to diagnosis and treatment still depend on where you live, who you see, or even your ethnicity? To mark World Asthma Day, we spoke with Carol...
Read More
New Data Highlights Urgent Need for Better Asthma Care – How FeNO Testing Can Help Reduce Hospitalisations
Bedfont® Scientific Limited promotes FeNO testing for asthma management. Research from Asthma + Lung UK has found a significant rise in Accident and Emergency (A&E) visits from people experiencing breathing issues such as asthma. Asthma + Lung UK is a...
Read More
Bedfont® Scientific Limited Highlights FeNO Testing’s Role in Childhood Asthma for World Health Day 2025
How FeNO testing with the NObreath® can aid an early asthma diagnosis in children. As the world prepares to observe World Health Day on April 7th, 2025, Bedfont® Scientific Limited highlights the importance of early and accurate asthma diagnosis with...
Read More
World Health Day 2025: How FeNO Testing is Helping Children with Asthma
World Health Day is celebrated annually on April 7th to recognise the World Health Organisation’s (WHO) founding in 1948. The day aims to raise awareness about global health issues and efforts to address them. In 2019, 262 million people worldwide...
Read More
Categories
